Teva Pharma Industries Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +16.9% | +71.2% | -24.0% | -14.1% | -5.3% | -11.9% | -5.9% | -7.7% | -1.2% | -9.6% | +3.6% | |
| – | +27.8% | -7.8% | -9.3% | -10.3% | -2.4% | -3.4% | -3.3% | -4.2% | +3.6% | +0.5% | +11.1% | |
| – | +212.0% | -85.8% | -2.5% | +85.0% | +10.8% | +10.2% | -0.6% | +29.4% | +15.2% | +2.3% | +7.8% | |
| – | +212.0% | -85.8% | -2.5% | +85.0% | +10.8% | +10.2% | -0.6% | +29.4% | +15.2% | +2.3% | +7.8% | |
| – | -1.1% | +40.6% | -5.3% | -18.3% | -2.5% | -19.3% | -1.1% | -18.4% | -7.8% | -10.2% | +21.2% | |
| – | -9.3% | +24.9% | -0.6% | -3.9% | -6.5% | -0.4% | -13.3% | +0.4% | +4.9% | -25.2% | +5.7% | |
| – | +0.1% | +13.7% | +3.1% | -10.5% | -6.3% | -2.2% | -5.0% | +2.9% | – | – | – | |
| – | +3.4% | +133.4% | -36.0% | -12.3% | -0.3% | -17.0% | -2.8% | -12.0% | -2.6% | -11.8% | +5.6% | |
| – | +39.2% | +180.0% | -17.9% | -20.6% | -19.8% | -20.6% | -16.3% | -16.0% | -14.1% | -18.0% | -14.4% | |
| – | +5.5% | +138.0% | -10.4% | -13.5% | -5.5% | -6.7% | -8.0% | -2.8% | -0.2% | -4.9% | -2.3% | |
| – | +5.8% | +42.4% | -3.2% | -20.1% | -4.5% | -3.7% | -16.2% | +4.0% | +6.8% | +4.5% | +5.2% | |
| – | -10.0% | +106.7% | +11.3% | -39.2% | +5.8% | +35.9% | -55.3% | +47.9% | -20.7% | +6.5% | +2.2% | |
| – | -39.5% | +12.5% | -4.1% | -10.4% | -7.3% | +2.2% | -4.0% | +11.9% | +37.9% | -15.3% | +14.9% | |
| – | -2.6% | +289.6% | -11.4% | -7.4% | -8.0% | -7.5% | -4.9% | -11.6% | -4.9% | -11.9% | -6.3% | |
| – | +27.7% | +12.0% | -47.9% | -15.3% | -5.0% | -28.2% | +2.5% | -24.1% | -3.8% | -28.4% | +47.2% | |
| – | +2.9% | -8.4% | -127.9% | – | – | – | – | – | – | – | – | |
| – | +0.7% | +11.2% | +5.7% | +0.5% | +6.9% | +0.4% | +1.1% | +0.3% | +0.8% | +1.1% | +3.7% |
Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.